P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome.Passet, Marie;Boissel, Nicolas;Sigaux, François;Saillard, Colombe;Clappier, Emmanuelle;et.al.(2019) Blood — Vol. 133, n° 3, p. 280-284 (2019)
FilesPassetMBlood2018.pdf Open Access Adobe PDF1.04 MBDownloadDetailsAuthorsPasset, MarieAuthorBoissel, NicolasAuthorSigaux, FrançoisAuthorSaillard, ColombeAuthorGraux, CarlosUCLouvainAuthorClappier, EmmanuelleAuthorShow more AffiliationsUCLouvainSSS/IREC/MONT - Pôle Mont GodinneUCLouvain(MGD) Service d'hématologieShow moreCitations APA Chicago FWB Passet, M., Boissel, N., Sigaux, F., Saillard, C., Bargetzi, M., Ba, I., Thomas, X., Graux, C., Chalandon, Y., Leguay, T., Lengliné, E., Konopacki, J., Quentin, S., Delabesse, E., Lafage-Pochitaloff, M., Pastoret, C., Grardel, N., Asnafi, V., Lhéritier, V., et al. (2019). P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome. Blood, 133(3), 280-284. https://doi.org/10.1182/blood-2018-10-882142 (Original work published 2019)